<DOC>
	<DOC>NCT00078000</DOC>
	<brief_summary>Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.</brief_summary>
	<brief_title>A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Anthracycline and taxanerefractory or intolerant metastatic breast cancer Female Prior treatment with 3 or greater regimens of chemotherapy in the advanced/metastatic disease setting beyond those containing anthracyclines/taxanes.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>